E-LIB Suche - Ergebnisse für: Fradet, Y.

1

Efficacy and safety of pembrolizumab in metastatic urotheli..:

Balar, A.V. ; Castellano, D.E. ; Grivas, P....
Annals of Oncology. 34 (2023) 3 - p. 289-299 , 2023

Link: https://doi.org/10.1016/..

2

Targeting the androgen receptor axis to improve response to..:

Gris, T. ; Besançon, M. ; Joncas, F-H....
European Urology. 81 (2022) - p. S121 , 2022

Link: https://doi.org/10.1016/..

3

The prevalence of cardiovascular disease and its risk facto..:

Pinthus, J. ; Shayegan, B. ; Klotz, L....
European Urology Open Science. 19 (2020) - p. e2106 , 2020

Link: https://doi.org/10.1016/..

4

Randomized phase III KEYNOTE-045 trial of pembrolizumab ver..:

Fradet, Y. ; Bellmunt, J. ; Vaughn, D.J....
Annals of Oncology. 30 (2019) 6 - p. 970-976 , 2019

Link: https://doi.org/10.1093/..

5

Increased prostate cancer glucose metabolism detected by FD..:

Lavallee, E. ; Bergeron, M. ; Buteau, F.-A....
European Urology Supplements. 17 (2018) 2 - p. e1510 , 2018

Link: https://doi.org/10.1016/..

6

Pembrolizumab vs investigator-choice chemotherapy for previ..:

Necchi, A. ; Bellmunt, J. ; De Wit, R....
European Journal of Cancer. 72 (2017) - p. S2 , 2017

Link: https://doi.org/10.1016/..

7

The use of antibiotic prophylaxis in patients undergoing ra..:

Haider, M. ; Mayr, R. ; Fritsche, H.-M....
European Urology Supplements. 16 (2017) 3 - p. e462-e463 , 2017

Link: https://doi.org/10.1016/..

8

Prognostic Significance of Tonsil Expression and the Homolo..:

So, J. ; Chua, M.L.K. ; Lalonde, E....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. S113 , 2016

Link: https://doi.org/10.1016/..

9

322 Development and validation of a post-DRE urine-based mu..:

Haince, J-F. ; Beaudry, G. ; Paquet, E....
European Urology Supplements. 14 (2015) 2 - p. e322 , 2015

Link: https://doi.org/10.1016/..

10

897 Gender-specific differences in clinicopathologic outcom..:

Kluth, L.A. ; Rieken, M. ; Xylinas, E....
European Urology Supplements. 13 (2014) 1 - p. e897-e897a , 2014

Link: https://doi.org/10.1016/..

11

276 Impact of histological variants on oncological outcomes..:

Xylinas, E.N. ; Rink, M. ; Kluth, L....
European Urology Supplements. 12 (2013) 1 - p. e276-e277 , 2013

Link: https://doi.org/10.1016/..

12

97 Updated interim analysis (IA): Results of randomized pha..:

Van Poppel, H. ; Rathkopf, D. ; Smith, M.R....
European Urology Supplements. 12 (2013) 1 - p. e97-e98 , 2013

Link: https://doi.org/10.1016/..

13

577 Photodynamic diagnosis of non-muscle invasive bladder c..:

Burger, M. ; Grossman, H.B. ; Droller, M....
European Urology Supplements. 12 (2013) 1 - p. e577 , 2013

Link: https://doi.org/10.1016/..

14

911 Biopsy-specific PCA3-based prostate biopsy nomograms ar..:

Chun, F.K. ; Hansen, J. ; De La Taille, A....
European Urology Supplements. 11 (2012) 1 - p. e911-e911a , 2012

Link: https://doi.org/10.1016/..

15

786 Impact of extent of positive margins on different outco..:

Mauermann, J. ; Fradet, V. ; Hovington, H....
European Urology Supplements. 11 (2012) 1 - p. e786-e786a , 2012

Link: https://doi.org/10.1016/..